The goal of the GTMRx Institute is to ensure appropriate and personalized use of medication and gene therapies by advancing to a scientific, evidence-based and cost-effective decision-making process and a team-based, systematic approach to medication use. We believe this will offer consumers a personalized approach to medication use. For those who pay for care, it will create a reduction in total cost of care—saving lives and saving money.
Critical to this goal is our work sponsoring and supporting multi-stakeholder activities that will encourage practice transformation, create pathways for dissemination of evidence and innovation and encourage payment and policy reform.
At our February summit we will discuss how we can harness and scale what we know works from the decades of work happening across health care to integrate medication experts into the care team and to facilitate “whole-person” medication use. We’ll examine what we can do to fix the trial-and-error approach to medication use that’s costing 275,000 people their lives and $528 billion in waste that we all pay for.
Bipartisan Policy Center and GTMRx Institute Agenda and Registration
Registration is open to all who are working to Get the Medications Right. When you register, you can choose to attend in-person or to watch the live-stream.
February 6, 2020
Registration 8:00 a.m. – 8:30 a.m.
Event 8:30 a.m. – 10:30 a.m. EST
Bipartisan Policy Center
1225 Eye Street NW
Washington, DC 20005
Katherine Herring Capps
Executive Director and Co-founder, GTMRx
Carolyn Clancy, M.D.
Deputy Under Secretary for Discovery, Education and Affiliate Networks, Veterans Health Administration
Susan Dentzer, M.P.H.
Senior Policy Fellow, Robert J. Margolis Center of Health Policy, Duke University
Gregory Downing, DO, PhD
Founder, Innovation Horizons, LLC, & Co-Chair of Health Datapalooza
Michael Evans, RPh
Vice President Enterprise Pharmacy & Chief Pharmacy Officer, Geisinger
Elizabeth Fowler, J.D., Ph.D.
Executive Vice President of Programs, Commonwealth Fund
Anand Parekh, M.D.
Chief Medical Advisor, Bipartisan Policy Center
Dan Rehrauer, PharmD
Senior Manager, Medication Therapy Management Program, HealthPartners
Exclusively for Board-level and Executive Member-level organizations!
11 a.m. to 5 p.m. Invitation Only Executive Roundtable
Immediately following the morning event, GTMRx will host a by-invitation Executive Roundtable discussion with a small group of approximately 50 leaders representing those who pay for and those who deliver care. The participants will include representatives from the GTMRx Board of Directors, Executive Member organizations, GTMRx Workgroups and leaders within government agencies, health plans, health systems, patient advocacy groups and health care professional organizations.
Susan Dentzer, senior policy fellow, Duke-Margolis Center for Health Policy, also will facilitate the afternoon discussion, which will guide our work to optimize medication use, focusing in on those key areas critical to achieving system-wide transformation:
- Driving best practices and adoption of advanced diagnostics to advance precision medicine;
- Facilitating the broad practice adoption of comprehensive medication management throughout the continuum of care;
- Overcoming payment and policy barriers that inhibit broad adoption of a systematic approach to appropriate medication use and access across the health care continuum; and
- Ensuring the consistent visibility, adoption and advancement of the data, information technology and artificial intelligence systems necessary to advance adoption of comprehensive medication management models.
While this event is at capacity, newly joined Board-level and Executive Member-level organizations will be able to participate.
For more information, please contact Sandra Morris, Director of Business Development at the GTMRx Institute, at [email protected] or (703) 394-5398.
Resources by topic
Click to expand and collapse the categories.
Practice & Care Delivery Transformation
Payment and Policy Solutions
Precision Medicine Enablement via Advanced Diagnostics
HIT and AI to Support Optimized Medication Use